Updated News from after market close!
$ImmunityBio(IBRX.US$ Immunitybio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled With FDA to Discuss Registration Path for Anktiva in Lung Cancer! This is in addition to the approved ANKTIVA for market! This is now results from the LUNG cancer trial! WHEREAS the marketing approval is/was for BLADDER cancer!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
MooMamaLlama : I was just reading this.... I'm shocked its only up 9% atm?!
TrytosaveabitOP MooMamaLlama: Im sure it will be another day where a lot of the volume will be routed off exchange! I have a feeling that will continue to be the case until shorts start closing their positions? Grrr! BTW GM little gal! Hope you have a great day
MooMamaLlama TrytosaveabitOP: GM my friend
had a good one, public hol, market closed for Anzac Day 
settling into evening here with nice green premarkets and positive company news...yippee. Should set up for a nice few weeks if momentum keeps knocking down shorts 
TrytosaveabitOP MooMamaLlama: Sounds pretty good! Stack them profits!
Daight : can ss even lose? losing momentum= route to DP.
TrytosaveabitOP Daight: If some start to cover and they stop routing so much to DP sure?
MooMamaLlama TrytosaveabitOP: so far so good...but you know Mr Market can be an ass sometimes and flip that as soon as open bell rings
GL, hope he's good to you today 
TrytosaveabitOP MooMamaLlama: Oh yeah! I know all to well about how Mr Market operates! Hehehe! Thank you Darlin
MonkeyGee MooMamaLlama: me too. The strangest thing is that this stock has super low float. This news should have taken it over 20.
TrytosaveabitOP MonkeyGee: Almost 55 million shares sold short! Market Makers are not letting this run! They are routing about 50% of volume off exchange so it never sees the board! Hehehe
View more comments...